Annual Net Income:
$444.09M+$162.50M(+57.71%)Summary
- As of today, HALO annual net profit is $444.09 million, with the most recent change of +$162.50 million (+57.71%) on December 31, 2024.
- During the last 3 years, HALO annual net income has risen by +$41.38 million (+10.28%).
- HALO annual net income is now at all-time high.
Performance
HALO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
$165.16M+$47.06M(+39.85%)Summary
- As of today, HALO quarterly net profit is $165.16 million, with the most recent change of +$47.06 million (+39.85%) on June 30, 2025.
- Over the past year, HALO quarterly net income has increased by +$71.92 million (+77.12%).
- HALO quarterly net income is now -23.74% below its all-time high of $216.59 million, reached on September 30, 2021.
Performance
HALO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
$557.28M+$71.92M(+14.82%)Summary
- As of today, HALO TTM net profit is $557.28 million, with the most recent change of +$71.92 million (+14.82%) on June 30, 2025.
- Over the past year, HALO TTM net income has increased by +$219.99 million (+65.22%).
- HALO TTM net income is now at all-time high.
Performance
HALO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
HALO Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +57.7% | +77.1% | +65.2% |
| 3Y3 Years | +10.3% | +628.1% | +52.2% |
| 5Y5 Years | +714.7% | +539.7% | +2489.1% |
HALO Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +119.7% | at high | +316.9% | at high | +206.8% |
| 5Y | 5-Year | at high | +714.7% | -23.7% | +628.1% | at high | +2489.1% |
| All-Time | All-Time | at high | +531.1% | -23.7% | +580.2% | at high | +564.4% |
HALO Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $165.16M(+39.9%) | $557.28M(+14.8%) |
| Mar 2025 | - | $118.09M(-13.8%) | $485.36M(+9.3%) |
| Dec 2024 | $444.09M(+57.7%) | $137.01M(+0.0%) | $444.09M(+13.2%) |
| Sep 2024 | - | $137.01M(+46.9%) | $392.47M(+16.4%) |
| Jun 2024 | - | $93.25M(+21.4%) | $337.29M(+5.8%) |
| Mar 2024 | - | $76.82M(-10.0%) | $318.80M(+13.2%) |
| Dec 2023 | $281.59M(+39.3%) | $85.39M(+4.3%) | $281.59M(+10.9%) |
| Sep 2023 | - | $81.84M(+9.5%) | $253.91M(+8.6%) |
| Jun 2023 | - | $74.75M(+88.7%) | $233.71M(+28.7%) |
| Mar 2023 | - | $39.62M(-31.3%) | $181.64M(-10.1%) |
| Dec 2022 | $202.13M(-49.8%) | $57.70M(-6.4%) | $202.13M(-4.3%) |
| Sep 2022 | - | $61.63M(+171.7%) | $211.20M(-42.3%) |
| Jun 2022 | - | $22.68M(-62.3%) | $366.15M(-15.8%) |
| Mar 2022 | - | $60.11M(-10.0%) | $434.92M(+8.0%) |
| Dec 2021 | $402.71M(+212.0%) | $66.77M(-69.2%) | $402.71M(-1.6%) |
| Sep 2021 | - | $216.59M(+136.8%) | $409.10M(+78.9%) |
| Jun 2021 | - | $91.46M(+227.9%) | $228.72M(+40.3%) |
| Mar 2021 | - | $27.89M(-61.9%) | $163.08M(+26.3%) |
| Dec 2020 | $129.09M(+278.7%) | $73.16M(+102.1%) | $129.09M(+499.7%) |
| Sep 2020 | - | $36.21M(+40.2%) | $21.52M(+154.2%) |
| Jun 2020 | - | $25.82M(+523.0%) | -$39.70M(+50.5%) |
| Mar 2020 | - | -$6.10M(+82.3%) | -$80.14M(-10.9%) |
| Dec 2019 | -$72.24M(+10.1%) | -$34.40M(-37.5%) | -$72.24M(-80.7%) |
| Sep 2019 | - | -$25.02M(-71.1%) | -$39.97M(+6.6%) |
| Jun 2019 | - | -$14.62M(-914.3%) | -$42.80M(+16.2%) |
| Mar 2019 | - | $1.80M(+184.5%) | -$51.07M(+36.4%) |
| Dec 2018 | -$80.33M(-227.6%) | -$2.13M(+92.4%) | -$80.33M(-275.9%) |
| Sep 2018 | - | -$27.85M(-21.7%) | $45.68M(-40.1%) |
| Jun 2018 | - | -$22.89M(+16.6%) | $76.28M(+11.5%) |
| Mar 2018 | - | -$27.46M(-122.2%) | $68.41M(+8.6%) |
| Dec 2017 | $62.97M(+161.1%) | $123.88M(+4406.4%) | $62.97M(+171.3%) |
| Sep 2017 | - | $2.75M(+108.9%) | -$88.30M(+26.4%) |
| Jun 2017 | - | -$30.76M(+6.5%) | -$119.99M(-3.3%) |
| Mar 2017 | - | -$32.90M(-20.1%) | -$116.10M(-12.7%) |
| Dec 2016 | -$103.02M(-219.6%) | -$27.39M(+5.4%) | -$103.02M(-44.5%) |
| Sep 2016 | - | -$28.95M(-7.7%) | -$71.32M(-6.7%) |
| Jun 2016 | - | -$26.88M(-35.6%) | -$66.83M(-80.9%) |
| Mar 2016 | - | -$19.82M(-558.9%) | -$36.94M(-14.6%) |
| Dec 2015 | -$32.23M(+52.9%) | $4.32M(+117.7%) | -$32.23M(+22.9%) |
| Sep 2015 | - | -$24.46M(-910.2%) | -$41.82M(-11.1%) |
| Jun 2015 | - | $3.02M(+120.0%) | -$37.64M(+33.9%) |
| Mar 2015 | - | -$15.11M(-186.5%) | -$56.94M(+16.7%) |
| Dec 2014 | -$68.38M(+18.1%) | -$5.27M(+74.0%) | -$68.38M(+19.6%) |
| Sep 2014 | - | -$20.28M(-24.6%) | -$85.09M(-1.2%) |
| Jun 2014 | - | -$16.27M(+38.7%) | -$84.10M(+7.3%) |
| Mar 2014 | - | -$26.55M(-20.7%) | -$90.74M(-8.7%) |
| Dec 2013 | -$83.48M | -$21.99M(-14.0%) | -$83.48M(-26.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$19.29M(+15.8%) | -$65.90M(+1.1%) |
| Jun 2013 | - | -$22.91M(-18.8%) | -$66.61M(-15.4%) |
| Mar 2013 | - | -$19.29M(-337.8%) | -$57.72M(-7.8%) |
| Dec 2012 | -$53.55M(-170.9%) | -$4.41M(+78.0%) | -$53.55M(+20.7%) |
| Sep 2012 | - | -$20.01M(-42.7%) | -$67.56M(-59.4%) |
| Jun 2012 | - | -$14.02M(+7.3%) | -$42.39M(-67.9%) |
| Mar 2012 | - | -$15.12M(+17.9%) | -$25.25M(-27.7%) |
| Dec 2011 | -$19.77M(+62.9%) | -$18.42M(-456.5%) | -$19.77M(-8.3%) |
| Sep 2011 | - | $5.17M(+65.7%) | -$18.25M(+49.1%) |
| Jun 2011 | - | $3.12M(+132.3%) | -$35.82M(+29.9%) |
| Mar 2011 | - | -$9.64M(+43.0%) | -$51.09M(+4.0%) |
| Dec 2010 | -$53.24M(+8.8%) | -$16.89M(-36.1%) | -$53.24M(-8.6%) |
| Sep 2010 | - | -$12.41M(-2.1%) | -$49.01M(+3.0%) |
| Jun 2010 | - | -$12.15M(-3.1%) | -$50.51M(+8.9%) |
| Mar 2010 | - | -$11.79M(+6.9%) | -$55.42M(+5.0%) |
| Dec 2009 | -$58.36M(-19.9%) | -$12.66M(+9.0%) | -$58.36M(+6.7%) |
| Sep 2009 | - | -$13.91M(+18.5%) | -$62.52M(-5.1%) |
| Jun 2009 | - | -$17.06M(-15.9%) | -$59.48M(-11.3%) |
| Mar 2009 | - | -$14.73M(+12.5%) | -$53.43M(-9.8%) |
| Dec 2008 | -$48.65M(-103.6%) | -$16.83M(-54.8%) | -$48.65M(-20.0%) |
| Sep 2008 | - | -$10.87M(+1.2%) | -$40.54M(-10.5%) |
| Jun 2008 | - | -$11.00M(-10.5%) | -$36.69M(-20.3%) |
| Mar 2008 | - | -$9.95M(-14.3%) | -$30.49M(-27.6%) |
| Dec 2007 | -$23.90M(-62.0%) | -$8.71M(-23.9%) | -$23.90M(-22.1%) |
| Sep 2007 | - | -$7.03M(-46.4%) | -$19.57M(-20.9%) |
| Jun 2007 | - | -$4.80M(-43.0%) | -$16.19M(-10.7%) |
| Mar 2007 | - | -$3.36M(+23.3%) | -$14.62M(+0.9%) |
| Dec 2006 | -$14.75M(-11.1%) | -$4.38M(-19.9%) | -$14.75M(-6.2%) |
| Sep 2006 | - | -$3.65M(-12.9%) | -$13.89M(+0.4%) |
| Jun 2006 | - | -$3.23M(+7.4%) | -$13.94M(-2.7%) |
| Mar 2006 | - | -$3.49M(+0.7%) | -$13.57M(-2.2%) |
| Dec 2005 | -$13.28M(-46.0%) | -$3.51M(+5.1%) | -$13.28M(-8.5%) |
| Sep 2005 | - | -$3.70M(-29.0%) | -$12.24M(-3.8%) |
| Jun 2005 | - | -$2.87M(+10.2%) | -$11.79M(-7.2%) |
| Mar 2005 | - | -$3.19M(-28.8%) | -$11.00M(-21.0%) |
| Dec 2004 | -$9.09M(>-9900.0%) | -$2.48M(+23.8%) | -$9.09M(-36.4%) |
| Sep 2004 | - | -$3.25M(-56.8%) | -$6.67M(-94.8%) |
| Jun 2004 | - | -$2.07M(-61.5%) | -$3.42M(-153.0%) |
| Mar 2004 | - | -$1.28M(-2282.9%) | -$1.35M(-1631.9%) |
| Dec 2003 | -$79.10K(-21.1%) | -$53.90K(-467.4%) | -$78.10K(-11.4%) |
| Sep 2003 | - | -$9500.00(-97.9%) | -$70.10K(+4.2%) |
| Jun 2003 | - | -$4800.00(+51.5%) | -$73.20K(+13.4%) |
| Mar 2003 | - | -$9900.00(+78.4%) | -$84.50K(-29.6%) |
| Dec 2002 | -$65.30K(-64.5%) | -$45.90K(-264.3%) | -$65.20K(-237.8%) |
| Sep 2002 | - | -$12.60K(+21.7%) | -$19.30K(-188.1%) |
| Jun 2002 | - | -$16.10K(-271.3%) | -$6700.00(-171.3%) |
| Mar 2002 | - | $9400.00 | $9400.00 |
| Dec 2001 | -$39.70K | - | - |
FAQ
- What is Halozyme Therapeutics, Inc. annual net profit?
- What is the all-time high annual net income for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. annual net income year-on-year change?
- What is Halozyme Therapeutics, Inc. quarterly net profit?
- What is the all-time high quarterly net income for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. quarterly net income year-on-year change?
- What is Halozyme Therapeutics, Inc. TTM net profit?
- What is the all-time high TTM net income for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. TTM net income year-on-year change?
What is Halozyme Therapeutics, Inc. annual net profit?
The current annual net income of HALO is $444.09M
What is the all-time high annual net income for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high annual net profit is $444.09M
What is Halozyme Therapeutics, Inc. annual net income year-on-year change?
Over the past year, HALO annual net profit has changed by +$162.50M (+57.71%)
What is Halozyme Therapeutics, Inc. quarterly net profit?
The current quarterly net income of HALO is $165.16M
What is the all-time high quarterly net income for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high quarterly net profit is $216.59M
What is Halozyme Therapeutics, Inc. quarterly net income year-on-year change?
Over the past year, HALO quarterly net profit has changed by +$71.92M (+77.12%)
What is Halozyme Therapeutics, Inc. TTM net profit?
The current TTM net income of HALO is $557.28M
What is the all-time high TTM net income for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high TTM net profit is $557.28M
What is Halozyme Therapeutics, Inc. TTM net income year-on-year change?
Over the past year, HALO TTM net profit has changed by +$219.99M (+65.22%)